A three molecule complex may be a target for treating Huntington’s disease, a genetic disorder affecting the brain. This finding by an international research team including scientists from the German…
The chemical compound known as “methylene blue” is a potential candidate for treating Alzheimer’s, as it prevents the harmful clumping of so-called tau proteins typically associated with this…
Goettingen, February 11th, 2013. When proteins get “out of shape”, the consequences can be fatal. They lose their function and in some cases form insoluble, toxic clumps that damage other cells and…
Magdeburg/London, January 18th, 2013. The brain can recall memories faster than previously assumed. A team of experts under the direction of neuroscientist Emrah Düzel, who is based in…
From January 2013: New site speaker at DZNE Witten
Bonn/Witten, January, 17th, 2013. Starting in January 2013, Professor Martina Roes will act as the new site speaker for the German Center for…
Federal Minister Schavan inaugurates new DZNE and University of Ulm institutes
Ulm, January 11th, 2013. Federal Research Minister Annette Schavan opened two new neuroscience institutes today in Ulm.…
Bonn, December 20th, 2012. Scientists at the German Center for Neurodegenerative Diseases (DZNE) in Bonn have gained new insights into the early phase of the brain’s development. In cooperation with…
Bonn, December 19th, 2012. Researchers in Bonn, Germany, have identified a protein as a potential target for the treatment of Alzheimer’s disease. The molecular complex is part of the immune…
Collaboration between two Helmholtz Centres: Neuroscientists and infection researchers focus on interdisciplinary partnership to study brain diseases
Bonn/Braunschweig, December 10th, 2012. Two…
